• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌复发的综合影像:CT 和 PET-CT 表现、可能的陷阱和复发标准的风险。

Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.

机构信息

Department of Bioimaging and Radiological Sciences, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.

出版信息

Eur Radiol. 2012 Mar;22(3):588-606. doi: 10.1007/s00330-011-2299-8. Epub 2011 Oct 4.

DOI:10.1007/s00330-011-2299-8
PMID:21969110
Abstract

OBJECTIVES

To review the role of imaging in the diagnosis of recurrent disease in previously treated non-small cell lung cancer (NSCLC) and discuss the imaging pitfalls.

METHODS

A comprehensive review of published literature on CT and PET imaging of NSCLC recurrence was performed. Diagnostic and prognostic values are discussed. Representative imaging examples are illustrated.

RESULTS

Up to 30% of NSCLC recurrences present as loco-regional, involving treated hemithorax and ipsilateral lymph nodes, while 70% present as metachronous distant metastases. CT and PET-CT play an important role in the early detection of recurrence; indications for imaging vary depending on pathological features.

CONCLUSION

Imaging plays a central role in the identification of recurrence and may predict prognosis.

KEY POINTS

Lung cancer recurs after surgery in 30% to 75% of patients. CT and PET-CT are crucial in identification of loco-regional recurrence. Knowledge of potential pitfalls is essential, especially for parenchymal or nodal recurrence. CT can diagnose metastases but further examinations (PET-CT, MRI) are often needed. Morphological and functional imaging criteria may help in predicting recurrence.

摘要

目的

回顾影像学在诊断经治非小细胞肺癌(NSCLC)复发中的作用,并讨论影像学中的陷阱。

方法

对 NSCLC 复发的 CT 和 PET 影像学的已发表文献进行了全面复习。讨论了诊断和预后价值。列举了有代表性的影像学实例。

结果

多达 30%的 NSCLC 复发表现为局部区域复发,累及治疗过的半胸和同侧淋巴结,而 70%表现为异时性远处转移。CT 和 PET-CT 在早期检测复发中发挥重要作用;影像学的适应证取决于病理特征。

结论

影像学在识别复发方面起着核心作用,并可能预测预后。

关键要点

手术后 30%至 75%的肺癌患者会复发。CT 和 PET-CT 对局部区域复发的识别至关重要。了解潜在的陷阱至关重要,特别是对于实质或淋巴结复发。CT 可诊断转移,但通常需要进一步检查(PET-CT、MRI)。形态和功能影像学标准有助于预测复发。

相似文献

1
Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.非小细胞肺癌复发的综合影像:CT 和 PET-CT 表现、可能的陷阱和复发标准的风险。
Eur Radiol. 2012 Mar;22(3):588-606. doi: 10.1007/s00330-011-2299-8. Epub 2011 Oct 4.
2
Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.正电子发射断层扫描结合诊断性胸部计算机断层扫描提高了立体定向体部放射治疗早期非小细胞肺癌后区域性复发的检出率。
J Thorac Cardiovasc Surg. 2013 Mar;145(3):709-15. doi: 10.1016/j.jtcvs.2012.12.024. Epub 2013 Jan 12.
3
18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对无症状非小细胞肺癌患者的术后随访很有用。
Interact Cardiovasc Thorac Surg. 2012 Nov;15(5):859-64. doi: 10.1093/icvts/ivs368. Epub 2012 Aug 21.
4
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.F18-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在非小细胞肺癌潜在根治性手术后患者中的临床价值:241例患者的经验
Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.
5
Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.正电子发射断层扫描评估立体定向体部放疗治疗非小细胞肺癌后局部失败。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1558-65. doi: 10.1016/j.ijrobp.2011.10.035. Epub 2012 May 7.
6
Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients.术后非小细胞肺癌患者使用 FDG-PET/CT 进行复发诊断和随访。
Gen Thorac Cardiovasc Surg. 2021 Feb;69(2):311-317. doi: 10.1007/s11748-020-01477-1. Epub 2020 Sep 9.
7
Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.非小细胞肺癌的术前分期:全身扩散加权磁共振成像与 18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的比较。
Eur Radiol. 2012 Dec;22(12):2859-67. doi: 10.1007/s00330-012-2542-y. Epub 2012 Jul 9.
8
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.正电子发射断层显像-计算机断层扫描用于评估疑似可切除非小细胞肺癌患者的纵隔淋巴结受累情况。
Cochrane Database Syst Rev. 2014 Nov 13;2014(11):CD009519. doi: 10.1002/14651858.CD009519.pub2.
9
Consistency and prognostic value of preoperative staging and postoperative pathological staging using F-FDG PET/MRI in patients with non-small cell lung cancer.正电子发射断层扫描/磁共振成像(F-FDG PET/MRI)在非小细胞肺癌患者术前分期和术后病理分期中的一致性和预后价值。
Ann Nucl Med. 2022 Dec;36(12):1059-1072. doi: 10.1007/s12149-022-01795-9. Epub 2022 Oct 20.
10
Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.超声、CT、MRI或PET-CT用于成人皮肤黑色素瘤的分期及再分期。
Cochrane Database Syst Rev. 2019 Jul 1;7(7):CD012806. doi: 10.1002/14651858.CD012806.pub2.

引用本文的文献

1
Values of circulating tumor DNA for non-small cell lung cancer patients receiving neoadjuvant therapy, progress and challenges: a narrative review.接受新辅助治疗的非小细胞肺癌患者循环肿瘤DNA的价值、进展与挑战:一项叙述性综述
J Thorac Dis. 2024 Jul 30;16(7):4742-4755. doi: 10.21037/jtd-24-265. Epub 2024 Jul 4.
2
Favourable surgical outcomes for either second primary lung cancer or intrapulmonary metastasis after resection of non-small-cell lung cancer.非小细胞肺癌切除术后,无论是第二原发性肺癌还是肺内转移,手术结果均良好。
Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2). doi: 10.1093/icvts/ivae009.
3
Evaluation of hypermetabolic mediastinal-hilar lymph nodes determined by PET/CT with EBUS-TBNA and calculation of SUVmax cutoff values in differentiation of malignancy.

本文引用的文献

1
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
2
Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinoma.早期非小细胞肺癌非手术治疗后治疗反应的评估。
Cancer J. 2011 Jan-Feb;17(1):38-48. doi: 10.1097/PPO.0b013e31820a0948.
3
Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.FDG PET/CT 在判断良恶性支气管阻塞中的作用。
评估 PET/CT 联合 EBUS-TBNA 检测到的高代谢性纵隔/肺门淋巴结,并计算 SUVmax 截断值以区分良恶性。
Medicine (Baltimore). 2023 Sep 1;102(35):e34928. doi: 10.1097/MD.0000000000034928.
4
Unusual Periaortic Mediastinal Recurrence of Pulmonary Adenocarcinoma: When Making Diagnosis Is Really Necessary.肺腺癌罕见的主动脉周围纵隔复发:何时确实需要进行诊断
Case Rep Oncol. 2022 Mar 21;15(1):300-304. doi: 10.1159/000523736. eCollection 2022 Jan-Apr.
5
TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-κB Signaling Cascade.TIPE2 通过调节 Akt/mTOR/NF-κB 信号级联促进肺癌细胞的增殖、存活和迁移。
Biomolecules. 2019 Dec 6;9(12):836. doi: 10.3390/biom9120836.
6
SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.SEOM-SERAM-SEMNIM 指南:在晚期非小细胞肺癌中使用功能和分子成像技术。
Clin Transl Oncol. 2018 Jul;20(7):837-852. doi: 10.1007/s12094-017-1795-y. Epub 2017 Dec 18.
7
Non-small cell lung cancer: quantitative phenotypic analysis of CT images as a potential marker of prognosis.非小细胞肺癌:CT 图像的定量表型分析作为一种潜在的预后标志物。
Sci Rep. 2016 Dec 6;6:38282. doi: 10.1038/srep38282.
8
Microscopic Invasions, Prognoses, and Recurrence Patterns of Stage I Adenocarcinomas Manifesting as Part-Solid Ground-Glass Nodules: Comparison With Adenocarcinomas Appearing as Solid Nodules After Matching Their Solid Parts' Size.表现为部分实性磨玻璃结节的Ⅰ期腺癌的微观浸润、预后及复发模式:与实性部分大小匹配后表现为实性结节的腺癌的比较
Medicine (Baltimore). 2016 Apr;95(15):e3419. doi: 10.1097/MD.0000000000003419.
9
FDG uptake at the bronchial stump after curative lobectomy for non-small cell lung cancer.非小细胞肺癌根治性肺叶切除术后支气管残端的氟代脱氧葡萄糖摄取情况。
Eur J Nucl Med Mol Imaging. 2016 May;43(5):832-838. doi: 10.1007/s00259-015-3234-z. Epub 2015 Oct 28.
10
Post-therapeutic positron emission tomography/computed tomography for early detection of non-small cell lung cancer recurrence.治疗后正电子发射断层扫描/计算机断层扫描在非小细胞肺癌复发早期检测中的应用。
Transl Lung Cancer Res. 2013 Aug;2(4):295-303. doi: 10.3978/j.issn.2218-6751.2013.05.02.
Eur Radiol. 2011 May;21(5):1077-87. doi: 10.1007/s00330-010-2006-1. Epub 2010 Nov 27.
4
18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.18F-FDG PET/CT 用于预测和检测恶性肺病变射频消融后的局部复发。
J Nucl Med. 2010 Dec;51(12):1833-40. doi: 10.2967/jnumed.110.076778. Epub 2010 Nov 15.
5
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.早期及局部晚期(非转移性)非小细胞肺癌:ESMO临床诊断、治疗及随访实践指南
Ann Oncol. 2010 May;21 Suppl 5:v103-15. doi: 10.1093/annonc/mdq207.
6
Non-small cell carcinoma: comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations.非小细胞癌:定性和/或定量评估的 FDG-PET/CT 与标准影像学检查对术后胸内和胸外复发评估能力的比较。
Eur J Radiol. 2011 Sep;79(3):473-9. doi: 10.1016/j.ejrad.2010.04.027. Epub 2010 May 23.
7
Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.I期非小细胞肺癌的立体定向体部放射治疗(立体定向消融放疗)——放射生物学、技术及临床结果的更新
Discov Med. 2010 May;9(48):411-7.
8
The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?立体定向体部放疗在非小细胞肺癌治疗中的作用:不能手术的患者的新兴标准?
Curr Oncol Rep. 2010 Jul;12(4):235-41. doi: 10.1007/s11912-010-0108-1.
9
Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension.最大径达 3cm 的 I 期非小细胞肺癌患者的长期生存和复发风险因素。
Chest. 2010 Aug;138(2):357-62. doi: 10.1378/chest.09-3046. Epub 2010 Apr 30.
10
Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up.完全切除后 5 年以上的非小细胞肺癌的晚期复发:患者随访中的发生率和临床意义。
Chest. 2010 Jul;138(1):145-50. doi: 10.1378/chest.09-2361. Epub 2010 Apr 9.